in the programmed
activation of mobile genetic elements, which is reflected in changes in the body’s epigenetic
, the only effective drugs for the treatment of tumor syndrome in NF1 are inhibitors of mitogen-
activatedAhmad, S.,
Abbas, M.,
Ullah, M.F.,
Aziz, M.H.,
Beylerli, O.,
Alam, M.A.,
Syed, M.A.,
Uddin, S.,
Ahmad, A. (2022) consistently shown to inhibit NF-κB
activation via inhibition of IκBα phosphorylation and the resulting